IGC Pharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- IGC Pharma Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- IGC
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0001326205
Board of directors
-
Claudia Grimaldi · DirectorSince 2024
-
James P. Moran · DirectorSince 2023
-
Ram Mukunda · Director · CEOSince 2023
-
Richard K. Prins · DirectorSince 2023
-
Terry L. Lierman · DirectorSince 2024
Chief executives
Ram Mukunda
· CEO
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Richard K. Prins
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 25, 2024 | James P. Moran Director | Open-market purchase | +588,235 | $0.34 | $200,000 |
| Mar 22, 2024 | Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857) 10% owner | Grant or award | +8,823,529 | $0.34 | $3,000,000 |
| Mar 13, 2024 | Ram Mukunda Director, Officer (CEO) | Option exercise | +333,333 | — | — |
| Mar 13, 2024 | Claudia Grimaldi Director | Option exercise | +83,333 | — | — |
| Mar 13, 2024 | Richard K. Prins Director | Option exercise | +100,000 | — | — |
| Mar 13, 2024 | James P. Moran Director | Option exercise | +50,000 | — | — |
| Mar 13, 2024 | Ram Mukunda Director, Officer (CEO) | Option exercise | +233,334 | — | — |
| Mar 13, 2024 | Claudia Grimaldi Director | Option exercise | +58,333 | — | — |
| Mar 13, 2024 | Richard K. Prins Director | Option exercise | +58,333 | — | — |
| Mar 13, 2024 | James P. Moran Director | Option exercise | +33,334 | — | — |
| Mar 13, 2024 | Ram Mukunda Director, Officer (CEO) | Option exercise | +333,334 | — | — |
| Mar 13, 2024 | Claudia Grimaldi Director | Option exercise | +100,000 | — | — |
| Mar 13, 2024 | Richard K. Prins Director | Option exercise | +100,000 | — | — |
| Mar 13, 2024 | James P. Moran Director | Option exercise | +80,000 | — | — |
| Mar 13, 2024 | Ram Mukunda Director, Officer (CEO) | Option exercise | +251,250 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.